Pharmagene Discovery Services Limited
Telephone: 01763 211600
Originally founded in 1996 and operating from laboratories in Royston, UK, Pharmagene Discovery Services (Pharmagene) is built upon the scientific knowledge, expertise and reputation of its legacy, and remains one of the earliest established companies to focus on human tissue-based research.
Pharmagene delivers tailored scientific solutions using human biospecimens in vitro to characterise disease and validate therapeutic targets & biomarkers to advance human health, from quantitative target expression, interrogation of spatial biology, functional cellular biology & bioassays, to biotherapeutic safety testing . The facility operates to GLP and is licenced by the UK Human Tissue Authority.
Pharmagene has created and curates an in-house human tissue biorepository to support research for its clients, and in addition offers sample processing and biostorage services.
With a wealth of knowledge of the human tissue research sector, and having conducted hundreds of studies for life science researchers around the world over the past three decades, the business is uniquely placed to support its clients to develop safe and efficacious new therapies and associated biomarkers more rapidly and with greater confidence.
Pharmagene delivers tailored scientific solutions using human biospecimens in vitro to characterise disease and validate therapeutic targets & biomarkers to advance human health, from quantitative target expression, interrogation of spatial biology, functional cellular biology & bioassays, to biotherapeutic safety testing . The facility operates to GLP and is licenced by the UK Human Tissue Authority.
Pharmagene has created and curates an in-house human tissue biorepository to support research for its clients, and in addition offers sample processing and biostorage services.
With a wealth of knowledge of the human tissue research sector, and having conducted hundreds of studies for life science researchers around the world over the past three decades, the business is uniquely placed to support its clients to develop safe and efficacious new therapies and associated biomarkers more rapidly and with greater confidence.